Budesonide ММХ in the treatment of ulcerative colitis: real world clinical practice

Rationale: Mild and moderate ulcerative colitis (UC) is conventionally treated with oral and rectal 5-aminosalicylic acid (5-ASA) formulations and, if ineffective, with systemic glucocorticosteroids. A huge disadvantage of systemic steroids is that with highly efficacy they have severe side effects...

詳細記述

書誌詳細

出版年:	Alʹmanah Kliničeskoj Mediciny
主要な著者:	P. A. Makarchuk, O. S. Britkina, E. A. Belousova
フォーマット:	論文
言語:	ロシア語
出版事項:	MONIKI 2019-12-01
主題:	ulcerative colitis remission induction topical steroids budesonide mmx
オンライン･アクセス:	https://www.almclinmed.ru/jour/article/view/1187